Literature DB >> 30171285

[When A is not A anymore: problems and pitfalls with blood group typing].

P Möhnle1, A Humpe2, G Wittmann2.   

Abstract

Correct blood group typing is a prerequisite for transfusion. In most cases blood group determination is without problems; however, in individual cases various factors can complicate blood group determination and sometimes lead to confusing findings. For a better understanding the clinician should have basic knowledge of blood typing. Blood group determination usually covers the AB0 blood groups, Rhesus and Kell systems; in addition, a direct Coombs test and an antibody screening test for the detection of irregular antibodies in the recipient are performed. Confusion of patients, blood samples, results or preparations can lead to severe consequences due to incompatible transfusion and must be prevented. In this context, bedside blood type testing before transfusion is of utmost importance. Problems in laboratory analysis as well as patient-related factors, such as the existence of irregular antibodies against red blood cells can complicate the immunohematology diagnostics. Certain medications, such as daratumumab, lead to a significantly increased complexity in laboratory analyses. Massive transfusions can lead to chimerism with more than one population of circulating red blood cells. Hematopoetic stem cell transplantation can also lead to a change in blood groups as well as chimerism. In addition, there are various other rare causes that can result in difficulties in blood group determination, such as rare blood groups or rare disease-associated phenomena. In the case of problems in blood group determination, early and close cooperation with transfusion medicine is essential for the clinician.

Entities:  

Keywords:  Blood banks; Blood group antigens; Blood group determination; Blood transfusion; Transfusion medicine

Year:  2018        PMID: 30171285     DOI: 10.1007/s00101-018-0483-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  25 in total

Review 1.  Red blood cell polyagglutination: clinical aspects.

Authors:  M L Beck
Journal:  Semin Hematol       Date:  2000-04       Impact factor: 3.851

Review 2.  What a difference 2 nucleotides make: a short review of ABO genetics.

Authors:  Mark H Yazer
Journal:  Transfus Med Rev       Date:  2005-07

Review 3.  Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Authors:  Patricia M Kopko
Journal:  Transfus Med Hemother       Date:  2015-10-29       Impact factor: 3.747

4.  Fatal hemolytic transfusion reaction resulting from ABO mistyping of a patient with acquired B antigen detectable only by some monoclonal anti-B reagents.

Authors:  G Garratty; P Arndt; A Co; K Rodberg; M Furmanski
Journal:  Transfusion       Date:  1996-04       Impact factor: 3.157

5.  A dispermic chimerism in a 2-year-old Caucasian boy.

Authors:  L M Repas-Humpe; A Humpe; R Lynen; B Glock; E M Dauber; G Simson; W R Mayr; M Köhler; S Eber
Journal:  Ann Hematol       Date:  1999-09       Impact factor: 3.673

6.  SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.

Authors:  P H B Bolton-Maggs
Journal:  Transfus Med       Date:  2016-12       Impact factor: 2.019

7.  When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy.

Authors:  Marlies Oostendorp; Jeroen J Lammerts van Bueren; Parul Doshi; Imran Khan; Tahamtan Ahmadi; Paul W H I Parren; Wouter W van Solinge; Karen M K De Vooght
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

8.  A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion.

Authors:  N M Heddle; R L Soutar; P L O'Hoski; J Singer; J A McBride; M A Ali; J G Kelton
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

9.  Association between alloantibody specificity and autoantibodies to red blood cells.

Authors:  Norbert Ahrens; Axel Pruss; Beate Mayer; Ramona Genth; Holger Kiesewetter; Abdulgabar Salama
Journal:  Transfusion       Date:  2007-10-17       Impact factor: 3.157

10.  Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia.

Authors:  G W Bird; J Wingham; M J Pippard; J G Hoult; V Melikian
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

View more
  2 in total

1.  [The patient blood group-the small but important difference].

Authors:  R Zimmermann; H Hackstein
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

2.  The development of a legal framework for blood donation and blood safety in China over 24 years.

Authors:  Dajun Gao; Heng Li; Kang Wang
Journal:  BMC Health Serv Res       Date:  2020-11-30       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.